Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

19.19
-0.7200-3.62%
Post-market: 19.470.2800+1.46%17:03 EDT
Volume:1.82M
Turnover:35.26M
Market Cap:3.73B
PE:-38.32
High:19.88
Open:19.70
Low:19.15
Close:19.91
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.39
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.04
PE(LYR):-11.85

Loading ...

HHLR's Q1 Portfolio: Capital Flows to Semiconductor Sector, PDD and Alibaba Remain Top Holdings

Stock News
·
May 16

These Analysts Revise Their Forecasts On Legend Biotech After Q1 Results

Benzinga Earnings
·
May 14

Legend Biotech price target lowered to $48 from $49 at Morgan Stanley

TIPRANKS
·
May 14

Legend Biotech Is Maintained at Outperform by RBC Capital

Dow Jones
·
May 13

Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says

MT Newswires Live
·
May 13

Legend Biotech price target raised to $64 from $62 at RBC Capital

TIPRANKS
·
May 13

RBC Lifts Price Target on Legend Biotech to $64 From $62, Keeps Outperform Rating

MT Newswires Live
·
May 13

Analysts Are Bullish on These Healthcare Stocks: AnaptysBio (ANAB), Legend Biotech (LEGN)

TIPRANKS
·
May 13

Barclays Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
May 13

Legend Biotech Corp : TD Cowen Raises Target Price to $29 From $21

THOMSON REUTERS
·
May 13

GENSCRIPT BIO Surges Over 5% as Associate Legend Biotech Reports Narrowed Loss and Strong CARVYKTI® Sales Growth

Stock News
·
May 13

Legend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss

Simply Wall St.
·
May 13

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Tvardi Therapeutics (TVRD) and Organigram Global (OGI)

TIPRANKS
·
May 13

Legend Biotech Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Legend Biotech reports Q1 EPS (3c), consensus (17c)

TIPRANKS
·
May 12

Genscript flags Legend Biotech Q1 results and cautions investors on risk

TIPRANKS
·
May 12

Legend Biotech Q1 2026 Results Show CARVYKTI-Fueled Revenue Surge and Narrowing Losses

TIPRANKS
·
May 12

Legend Biotech Q1 revenue slightly misses estimates

Reuters
·
May 12

Legend Biotech Q1 FY26 net loss narrows 46.24% to $54.3 million; revenue rises to $305.1 million

Reuters
·
May 12

Legend Biotech Q1 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $305.100M Miss $307.035M Estimate

Benzinga Earnings
·
May 12